Idera Pharmaceuticals Announces Issuance of US Patent for Oligonucleotide Compositions that Activate Toll-Like Receptors
Idera Pharmaceuticals Announces Issuance of US Patent for Oligonucleotide Compositions that Activate Toll-Like Receptors
Feb 14, 2007
Click here to access PDF press release.